RT Journal Article
SR Electronic
T1 Prevalence of Function-Limiting Late Effects in Hodgkin Lymphoma Survivors
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.02.20202408
DO 10.1101/2020.10.02.20202408
A1 Enam, Nabela
A1 Chou, Kathy
A1 Stubblefield, Michael D.
YR 2020
UL http://medrxiv.org/content/early/2020/10/05/2020.10.02.20202408.abstract
AB Objective To define the prevalence of neuromuscular, musculoskeletal, pain, visceral, oncologic and other late effects impacting function and quality of life in Hodgkin lymphoma(HL) survivors presenting to an outpatient cancer rehabilitation clinic.Design A retrospective cohort analysis.Setting Outpatient cancer rehabilitation clinic.Participants One hundred consecutive HL survivors.Interventions None.Main Outcome Measures The prevalence of neuromuscular, musculoskeletal, pain, visceral, oncologic and other late effects contributing to functional impairment and disability in HL survivors.Results Among the 100 HL survivors, 43% received chemotherapy, 94% radiation therapy, and 38% a combination of chemotherapy and radiation for initial treatment. Nearly all HL survivors were diagnosed with myelopathy (83%), radiculo-plexopathy (93%), mononeuropathy (95%) and localized myopathy (93%). Musculoskeletal sequelae were extremely common and included dropped head syndrome (83%), cervicalgia (79%), shoulder girdle dysfunction (73%), and dysphagia (42%). Visceral disorders were also common and included cardiovascular (70%), pulmonary (44%), endocrine (63%), gastrointestinal (29%), and genitourinary (11%) dysfunction. Lymphedema affected 21% of survivors and 30% had a history of a secondary malignancy. Pain (71%), fatigue (45%), and dyspnea (43%) were major function-limiting impairments. Nearly all (95%) of survivors were referred to at least one therapy discipline including physical therapy, occupational therapy, speech and language pathology and/or lymphedema therapy.Conclusion Neuromuscular, musculoskeletal, pain, visceral, oncologic and other late effectsare extremely common in HL survivors seeking physiatric evaluation. Multiple function-limiting disorders can co-exist in HL survivors with the potential to severely compromise function and quality of life. Safe and effective rehabilitation may depend on the physiatrist’s ability to identify, evaluate and manage the multitude of complex and often interrelated functional late effects seen in HL survivors.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThere was no funding required to support the work presented.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Institutional Review Board at the Kessler Foundation.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData for 100 sequential patients previously diagnosed and treated for late effects of Hodgkin Lymphoma was available and included in the studyADLactivities of daily livingCMTcombined modality therapyDHSdropped head syndromeHLHodgkin lymphomaOToccupational therapyPTphysical therapyRTradiation therapySGDshoulder girdle dysfunctionSLPspeech and language pathology therapyQOLquality of life